NCT01237106

In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS)

In Vitro Maturation for Polycystic Ovary Syndrome (PCOS)- A Pilot Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: University Reproductive Associates · Academic / Other
• Sex: Female
• Age: 18 Years – 34 Years
• Healthy volunteers: Accepted

Summary

This pilot study will be a prospective investigation to study the efficacy and safety of In-Vitro Maturation (IVM) for women with Polycystic Ovarian Syndrome (PCOS). There will be 10 subjects total in this Study. There will be no blinding to treatment. In-Vitro Maturation will provide a viable, safe option for women with PCOS attempting pregnancy through the use of Assisted Reproductive Technology (ART).

Conditions

• Polycystic Ovarian Syndrome

Interventions

Type	Name	Description
OTHER	IVM	all patients in this pilot study will undergo IVM. IVM involves immature eggs being retrieved and matured in the laboratory.After maturation they are fertilized like is done in a typical IVF cycle.

Timeline

• Start date: 2010-11-01
• Primary completion: 2012-02-01
• Completion: 2012-11-01
• First posted: 2010-11-09
• Last updated: 2015-12-03

Locations

2 sites across 1 country: United States